marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Apyx Medical Corporation Balance Sheet 2011-2024 | APYX
Annual Balance Sheet Apyx Medical Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-10.1 M | -9.9 M | -30.7 M | -41.2 M | -57.7 M | -16.3 M | -7.12 M | -11.4 M | -8.49 M | -2.32 M | -4.67 M | -743 K | -664 K |
Long Term Debt |
33.2 M | 73 K | 18 K | - | - | 140 K | 2.6 M | 2.83 M | 3.07 M | 3.17 M | 3.18 M | 3.28 M | 3.63 M |
Long Term Debt Current |
347 K | 216 K | 122 K | 126 K | 108 K | - | 239 K | 239 K | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.1 M | 1.18 M | 140 K | 2.98 M | 3.62 M | 3.92 M | 16.4 M | 8.93 M | 3.37 M | 3.73 M |
Total Current Liabilities |
12.7 M | 11.8 M | 13.2 M | 9.15 M | 12.3 M | 8.61 M | 5.97 M | 5.27 M | 4.12 M | 3.77 M | 2.91 M | 1.92 M | 2.39 M |
Total Liabilities |
52.3 M | 14 M | 14.7 M | 10.3 M | 13.5 M | 7.84 M | 8.96 M | 8.89 M | 8.04 M | 20.1 M | 11.8 M | 5.29 M | 6.12 M |
Deferred Revenue |
500 K | 900 K | 500 K | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-54.4 M | -35.7 M | -12.6 M | 2.62 M | 14.5 M | 35.5 M | -28.5 M | -23.4 M | -19.5 M | -27.8 M | -9.63 M | -2.64 M | -3.26 M |
Total Assets |
79.2 M | 51.8 M | 68.7 M | 74.1 M | 84.7 M | 95.6 M | 31 M | 35.1 M | 31.4 M | 24.8 M | 33.2 M | 28.2 M | 28.2 M |
Cash and Cash Equivalents |
43.7 M | 10.2 M | 30.9 M | 41.9 M | 58.8 M | 16.6 M | 9.95 M | 14.5 M | 11.8 M | 5.73 M | 7.92 M | 4.16 M | 4.88 M |
Book Value |
26.9 M | 37.8 M | 54 M | 63.9 M | 71.3 M | 87.8 M | 22 M | 26.2 M | 23.4 M | 4.69 M | 21.3 M | 22.9 M | 22.1 M |
Total Shareholders Equity |
26.7 M | 37.6 M | 53.7 M | 63.7 M | 71.3 M | 87.2 M | 22 M | 26.2 M | 23.4 M | 1.5 M | 19.1 M | 22.9 M | 22.1 M |
All numbers in USD currency
Quarterly Balance Sheet Apyx Medical Corporation
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
33.9 M | 33.6 M | 33.2 M | 9.01 M | - | 8.78 M | 73 K | 78 K | 93 K | 13 K | 18 K | 22 K | 76 K | 107 K | 183 K | 183 K | 183 K | 183 K | 421 K | 421 K | 421 K | 421 K | - | - | 2.34 M | 2.4 M | 2.46 M | 2.46 M | 2.46 M | 2.46 M | 2.69 M | 2.69 M | 2.69 M | 2.69 M | 2.93 M | - | 140 K | 140 K | - | - | - | - | 3.18 M | 3.18 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
49.5 M | 50.5 M | 52.3 M | 25.9 M | - | 20.6 M | 14 M | 13.1 M | 13.3 M | 13.2 M | 14.7 M | 13.1 M | 11.9 M | 10.9 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 13.5 M | 13.5 M | 13.5 M | 13.5 M | 8.75 M | 7.72 M | 7.84 M | 7.84 M | 8.96 M | 8.96 M | 8.96 M | 8.96 M | 8.89 M | 8.89 M | 8.89 M | 8.89 M | 8.04 M | 8.04 M | 8.04 M | 8.04 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 5.29 M | 5.29 M | 5.29 M | 5.29 M | 6.12 M | 6.12 M | 6.12 M | 6.12 M |
Deferred Revenue |
- | - | - | - | - | 1.05 M | 853 K | - | - | 759 K | 533 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-73.3 M | -68.6 M | -54.4 M | -44.8 M | - | -39.2 M | -35.7 M | -29.7 M | -23.9 M | -18.5 M | -12.6 M | -10.5 M | -6.33 M | -2.28 M | 2.62 M | 2.62 M | 2.62 M | 2.62 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 34.2 M | 34.9 M | 35.5 M | 35.5 M | -28.5 M | -28.5 M | -28.5 M | -28.5 M | -23.4 M | -23.4 M | -23.4 M | -23.4 M | -19.5 M | -19.5 M | -19.5 M | -19.5 M | -27.8 M | -27.8 M | -27.8 M | -27.8 M | -9.63 M | -9.63 M | -9.63 M | -9.63 M | -2.64 M | -2.64 M | -2.64 M | -2.64 M | -3.26 M | -3.26 M | -3.26 M | -3.26 M |
Total Assets |
60.7 M | 65.4 M | 79.2 M | 59.4 M | - | 56.8 M | 51.8 M | 55.3 M | 59.5 M | 63 M | 68.7 M | 67.8 M | 69.6 M | 71.1 M | 74.1 M | 74.1 M | 74.1 M | 74.1 M | 84.7 M | 84.7 M | 84.7 M | 84.7 M | 95.9 M | 95.6 M | 95.6 M | 95.6 M | 31 M | 31 M | 31 M | 31 M | 35.1 M | 35.1 M | 35.1 M | 35.1 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 33.2 M | 33.2 M | 33.2 M | 33.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M | 28.2 M |
Cash and Cash Equivalents |
28 M | 32.7 M | 43.7 M | 22.1 M | 18.5 M | 16.3 M | 10.2 M | 14.8 M | 20.1 M | 26.2 M | 30.9 M | 30.9 M | 34.7 M | 39.5 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 58.8 M | 58.8 M | 58.8 M | 58.8 M | 16.6 M | 16.5 M | 16.5 M | 16.5 M | 9.95 M | 9.95 M | 9.95 M | 9.95 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 11.8 M | 11.8 M | 11.8 M | 11.8 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M | 7.92 M | 7.92 M | 7.92 M | 7.92 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | 4.88 M | 4.88 M | 4.88 M | 4.88 M |
Book Value |
11.2 M | 14.9 M | 26.9 M | 33.6 M | - | 36.2 M | 37.8 M | 42.2 M | 46.2 M | 49.8 M | 54 M | 54.7 M | 57.7 M | 60.2 M | 63.9 M | 63.9 M | 63.9 M | 63.9 M | 71.3 M | 71.3 M | 71.3 M | 71.3 M | 87.2 M | 87.9 M | 87.8 M | 87.8 M | 22 M | 22 M | 22 M | 22 M | 26.2 M | 26.2 M | 26.2 M | 26.2 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 4.69 M | 4.69 M | 4.69 M | 4.69 M | 21.3 M | 21.3 M | 21.3 M | 21.3 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M |
Total Shareholders Equity |
11 M | 14.7 M | 26.7 M | 33.6 M | 36.7 M | 36.1 M | 37.6 M | 42.2 M | 45.9 M | 49.8 M | 53.7 M | 54.7 M | 57.7 M | 60 M | 63.7 M | 63.7 M | 63.7 M | 63.7 M | 71.3 M | 71.3 M | 71.3 M | 71.3 M | 87.2 M | 87.9 M | 87.8 M | 87.2 M | 22 M | 22 M | 22 M | 22 M | 26.2 M | 26.2 M | 26.2 M | 26.2 M | 23.4 M | 23.4 M | 23.4 M | 23.4 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M |
All numbers in USD currency